Anatara Begin Period Cash Flow vs Stock Based Compensation Analysis

ANR Stock   0.06  0  1.72%   
Anatara Lifesciences financial indicator trend analysis is way more than just evaluating Anatara Lifesciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anatara Lifesciences is a good investment. Please check the relationship between Anatara Lifesciences Begin Period Cash Flow and its Stock Based Compensation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Begin Period Cash Flow vs Stock Based Compensation

Begin Period Cash Flow vs Stock Based Compensation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anatara Lifesciences Begin Period Cash Flow account and Stock Based Compensation. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Anatara Lifesciences' Begin Period Cash Flow and Stock Based Compensation is -0.07. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Stock Based Compensation in the same time period over historical financial statements of Anatara Lifesciences, assuming nothing else is changed. The correlation between historical values of Anatara Lifesciences' Begin Period Cash Flow and Stock Based Compensation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Anatara Lifesciences are associated (or correlated) with its Stock Based Compensation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Stock Based Compensation has no effect on the direction of Begin Period Cash Flow i.e., Anatara Lifesciences' Begin Period Cash Flow and Stock Based Compensation go up and down completely randomly.

Correlation Coefficient

-0.07
Relationship DirectionNegative 
Relationship StrengthInsignificant

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most indicators from Anatara Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anatara Lifesciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anatara Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to gain to about 1.6 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 1.8 M in 2024.
 2021 2022 2023 2024 (projected)
Cost Of Revenue24.7K24.8K748.9K786.4K
Research Development747.2K1.6M748.9K781.0K

Anatara Lifesciences fundamental ratios Correlations

0.330.80.230.360.330.25-0.520.311.00.66-0.810.250.430.99-0.160.261.00.70.920.29-0.130.150.18-0.180.52
0.330.060.540.860.68-0.1-0.560.790.30.51-0.08-0.520.210.250.37-0.260.33-0.040.330.73-0.320.030.08-0.08-0.09
0.80.060.2-0.030.230.47-0.430.040.820.55-1.00.250.410.82-0.170.040.80.570.620.14-0.260.180.16-0.170.19
0.230.540.20.40.74-0.27-0.570.690.220.49-0.22-0.61-0.060.130.49-0.260.23-0.260.280.77-0.890.130.16-0.15-0.51
0.360.86-0.030.40.490.02-0.420.760.310.430.01-0.330.080.250.21-0.080.35-0.170.340.55-0.050.180.25-0.250.12
0.330.680.230.740.49-0.14-0.890.60.320.79-0.26-0.810.520.250.71-0.430.33-0.020.290.94-0.650.090.11-0.1-0.46
0.25-0.10.47-0.270.02-0.14-0.16-0.110.250.25-0.470.290.280.28-0.250.190.250.27-0.13-0.330.320.020.02-0.020.23
-0.52-0.56-0.43-0.57-0.42-0.89-0.16-0.51-0.51-0.970.460.59-0.6-0.46-0.540.29-0.51-0.25-0.37-0.710.51-0.07-0.090.080.29
0.310.790.040.690.760.6-0.11-0.510.270.47-0.06-0.4-0.160.210.15-0.210.31-0.170.330.63-0.420.080.14-0.14-0.13
1.00.30.820.220.310.320.25-0.510.270.66-0.820.260.440.99-0.160.271.00.730.920.27-0.130.140.17-0.170.51
0.660.510.550.490.430.790.25-0.970.470.66-0.58-0.430.60.620.43-0.170.660.380.490.6-0.410.070.09-0.09-0.12
-0.81-0.08-1.0-0.220.01-0.26-0.470.46-0.06-0.82-0.58-0.21-0.43-0.830.13-0.03-0.81-0.57-0.62-0.170.28-0.17-0.150.16-0.18
0.25-0.520.25-0.61-0.33-0.810.290.59-0.40.26-0.43-0.21-0.280.33-0.90.570.250.450.25-0.790.60.050.05-0.050.78
0.430.210.41-0.060.080.520.28-0.6-0.160.440.6-0.43-0.280.460.41-0.150.430.530.260.390.010.030.02-0.020.06
0.990.250.820.130.250.250.28-0.460.210.990.62-0.830.330.46-0.220.290.990.780.910.2-0.060.120.15-0.150.57
-0.160.37-0.170.490.210.71-0.25-0.540.15-0.160.430.13-0.90.41-0.22-0.32-0.16-0.3-0.170.7-0.5-0.28-0.280.29-0.65
0.26-0.260.04-0.26-0.08-0.430.190.29-0.210.27-0.17-0.030.57-0.150.29-0.320.270.40.26-0.390.34-0.34-0.30.30.69
1.00.330.80.230.350.330.25-0.510.311.00.66-0.810.250.430.99-0.160.270.710.920.29-0.120.150.18-0.180.52
0.7-0.040.57-0.26-0.17-0.020.27-0.25-0.170.730.38-0.570.450.530.78-0.30.40.710.62-0.120.18-0.13-0.120.120.64
0.920.330.620.280.340.29-0.13-0.370.330.920.49-0.620.250.260.91-0.170.260.920.620.34-0.180.170.2-0.20.52
0.290.730.140.770.550.94-0.33-0.710.630.270.6-0.17-0.790.390.20.7-0.390.29-0.120.34-0.690.040.07-0.07-0.42
-0.13-0.32-0.26-0.89-0.05-0.650.320.51-0.42-0.13-0.410.280.60.01-0.06-0.50.34-0.120.18-0.18-0.69-0.1-0.10.10.64
0.150.030.180.130.180.090.02-0.070.080.140.07-0.170.050.030.12-0.28-0.340.15-0.130.170.04-0.10.99-0.99-0.04
0.180.080.160.160.250.110.02-0.090.140.170.09-0.150.050.020.15-0.28-0.30.18-0.120.20.07-0.10.99-1.00.0
-0.18-0.08-0.17-0.15-0.25-0.1-0.020.08-0.14-0.17-0.090.16-0.05-0.02-0.150.290.3-0.180.12-0.2-0.070.1-0.99-1.0-0.01
0.52-0.090.19-0.510.12-0.460.230.29-0.130.51-0.12-0.180.780.060.57-0.650.690.520.640.52-0.420.64-0.040.0-0.01
Click cells to compare fundamentals

Anatara Lifesciences Account Relationship Matchups

Anatara Lifesciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.3M4.3M1.8M1.4M1.7M1.6M
Total Current Liabilities464.0K402.6K358.1K494.2K304.2K369.0K
Cash2.7M3.4M1.1M351.2K982.1K933.0K
Net Receivables630.3K772.6K508.5K1.0M671.1K518.6K
Total Liab487.0K496.7K403.4K494.8K306.8K433.2K
Common Stock17.0M19.8M19.9M21.4M23.2M14.6M
Other Current Assets23.7K37.1K22.0K10.9K17.4K16.6K
Other Current Liab430.2K192.9K184.8K415.3K56.1K53.3K
Total Stockholder Equity2.9M3.8M1.4M924.5K1.4M1.3M
Net Debt(2.7M)(3.4M)(1.1M)(351.2K)(982.1K)(1.0M)
Retained Earnings(14.7M)(16.6M)(19.0M)(20.8M)(22.1M)(21.0M)
Accounts Payable33.9K195.6K152.6K78.8K248.0K149.2K
Cash And Short Term Investments2.7M3.4M1.2M401.2K982.1K933.0K
Common Stock Shares Outstanding54.6M69.0M78.2M104.3M150.0M157.5M
Liabilities And Stockholders Equity3.3M4.3M1.8M1.4M1.7M1.6M
Other Stockholder Equity(2.3M)(3.2M)(924.8K)(576.8K)(519.2K)(545.1K)
Total Current Assets3.3M4.2M1.7M1.4M1.7M1.6M
Net Tangible Assets2.9M3.8M1.4M924.5K832.1K790.5K
Property Plant And Equipment Net7.2K85.0K66.9K3.3K794.0754.3
Non Current Assets Total7.2K85.0K66.9K3.3K794.0754.3
Non Currrent Assets Other(27.2K)(7.2K)(85.0K)(66.9K)(3.3K)0.0
Short Term Investments6.2M4.1M0.050K50.1K47.6K
Property Plant And Equipment Gross7.2K85.9K87.8K3.3K794.0754.3
Accumulated Other Comprehensive Income553.3K678.5K439.5K347.7K278.0K442.9K
Property Plant Equipment7.2K85.0K66.9K3.3K3.7K3.6K
Non Current Liabilities Total22.9K94.1K45.2K665.02.7K2.6K
Net Invested Capital2.9M3.8M1.4M924.5K1.4M1.3M
Net Working Capital2.9M3.8M1.3M921.9K1.4M1.3M
Other Liab22.9K28.3K81.0665.0598.5568.57
Capital Stock17.0M19.8M19.9M21.4M23.2M21.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Anatara Stock Analysis

When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.